1 Reason to Buy NuScale Power and Hold Until 2033

NuScale Power remains the only U.S. nuclear company with an NRC-approved SMR design, but it has yet to commercialize the technology. The company’s first SMR project in Romania is expected to reach commercial operation in 2033, with 463 MWe planned at a former coal plant. The article is cautiously constructive, citing a potential $25 billion investment supporting nuclear power for AI, but it also notes the stock is still about 75% below its all-time high.

Analysis

The market is still pricing SMR as a pre-commercial science project, but the more important edge is regulatory optionality. An NRC-approved design creates a cleaner path to project finance, insurance, and utility procurement than competitors still forcing capital allocators to underwrite licensing risk; that should widen the valuation gap versus OKLO and NNE if the next 12-24 months produce even incremental execution milestones. The second-order winner may be the adjacent supply chain—heavy forgings, control systems, EPC services, and grid interconnect vendors—because the first bankable SMR wins often monetize through vendor lock-in before the reactor economics are fully proven.

The key underappreciated risk is not technology, but time compression versus capital dilution. A 2033 first commercial unit means a long runway where investor patience can be taxed by repeated financing rounds, permitting slippage, and headline risk from any nuclear incident globally; that makes the equity vulnerable to duration-like multiple compression whenever rates rise or risk appetite fades. In other words, the asset is more exposed to discount-rate changes than to near-term operating fundamentals, so the stock can underperform even if the strategic thesis remains intact.

Consensus may be overestimating how much SMR approval alone translates into monetizable demand. Utilities and sovereign counterparties will likely wait for a fully financed, reference plant with demonstrated uptime before committing large fleets, so the real re-rating catalyst is not approval but first concrete project economics in Romania and any credible capital commitment from ENTRA1/Japan-linked partners. If those slip, the stock can retrace quickly; if they land, the move can be abrupt because the market is underweight credible nuclear growth optionality.

Key Decisions for Investors

• Long SMR on weakness only, with a 6-12 month horizon; size modestly because the main risk is capital dilution before first cash-generating deployment, but upside can re-rate sharply on financing milestones.
• Pair trade: long SMR / short OKLO or NNE for 3-6 months; the spread should widen if the market continues to reward regulatory de-risking over speculative reactor narratives.
• Buy SMR call spreads 9-18 months out rather than stock if expressing upside to first project finance announcements; defined risk is preferable given long-dated execution risk and rate sensitivity.
• If you want lower-beta exposure to the theme, look to industrial and EPC beneficiaries with nuclear delivery exposure rather than reactor developers; these names monetize the buildout earlier and have better cash conversion.
• Trim or avoid chasing the move if SMR rallies on headlines without a signed financing package; that would be a momentum trade, not a fundamental rerating, and the downside can be severe on any delay.